Cargando…
Evaluating the cost-effectiveness of biologic treatments for psoriatic arthritis: can we make better use of patient data registries?
The primary aim of this study is to explore the extent to which registry data may fulfill the evidence requirements of cost-effectiveness analysis (CEA) studies evaluating biologic therapies for the treatment of psoriatic arthritis (PsA), where trial data are lacking or insufficient. In addition, th...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519654/ https://www.ncbi.nlm.nih.gov/pubmed/28612241 http://dx.doi.org/10.1007/s10067-017-3703-9 |